Kevin Evel-Kabler

764 total citations
7 papers, 633 citations indexed

About

Kevin Evel-Kabler is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Kevin Evel-Kabler has authored 7 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Kevin Evel-Kabler's work include Immunotherapy and Immune Responses (7 papers), vaccines and immunoinformatics approaches (3 papers) and Immune Response and Inflammation (3 papers). Kevin Evel-Kabler is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), vaccines and immunoinformatics approaches (3 papers) and Immune Response and Inflammation (3 papers). Kevin Evel-Kabler collaborates with scholars based in United States, Slovakia and France. Kevin Evel-Kabler's co-authors include Lei Shen, Si‐Yi Chen, Xiao‐Tong Song, Lisa Rollins, Xue F. Huang, Si–Yi Chen, Melissa B. Aldrich, Feng Gao, Si-Yi Chen and Xue F. Huang and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Biotechnology.

In The Last Decade

Kevin Evel-Kabler

7 papers receiving 618 citations

Peers

Kevin Evel-Kabler
Nourredine Himoudi United Kingdom
Joanna Stanson United States
Lorenzo Uccellini United States
Bas Pilzecker Netherlands
Susanne Oberle Switzerland
R Brew United Kingdom
Irina Smirnow Germany
Salim Dhanji Canada
Shengwu Liu China
Matthew F. Mackey United States
Nourredine Himoudi United Kingdom
Kevin Evel-Kabler
Citations per year, relative to Kevin Evel-Kabler Kevin Evel-Kabler (= 1×) peers Nourredine Himoudi

Countries citing papers authored by Kevin Evel-Kabler

Since Specialization
Citations

This map shows the geographic impact of Kevin Evel-Kabler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Evel-Kabler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Evel-Kabler more than expected).

Fields of papers citing papers by Kevin Evel-Kabler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Evel-Kabler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Evel-Kabler. The network helps show where Kevin Evel-Kabler may publish in the future.

Co-authorship network of co-authors of Kevin Evel-Kabler

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Evel-Kabler. A scholar is included among the top collaborators of Kevin Evel-Kabler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Evel-Kabler. Kevin Evel-Kabler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hong, Bangxing, Wenhong Ren, Xiao‐Tong Song, et al.. (2009). Human Suppressor of Cytokine Signaling 1 Controls Immunostimulatory Activity of Monocyte-Derived Dendritic Cells. Cancer Research. 69(20). 8076–8084. 33 indexed citations
2.
Song, Xiao‐Tong, Kevin Evel-Kabler, Lei Shen, et al.. (2008). A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell–mediated suppression. Nature Medicine. 14(3). 258–265. 134 indexed citations
3.
Evel-Kabler, Kevin & Si‐Yi Chen. (2006). Inhibition of antigen-presentation attenuators to augment vaccines.. PubMed. 8(1). 24–30. 4 indexed citations
4.
Evel-Kabler, Kevin & Si‐Yi Chen. (2006). Dendritic Cell-Based Tumor Vaccines and Antigen Presentation Attenuators. Molecular Therapy. 13(5). 850–858. 24 indexed citations
5.
Song, Xiao‐Tong, Kevin Evel-Kabler, Lisa Rollins, et al.. (2005). An Alternative and Effective HIV Vaccination Approach Based on Inhibition of Antigen Presentation Attenuators in Dendritic Cells. PLoS Medicine. 3(1). e11–e11. 69 indexed citations
6.
Evel-Kabler, Kevin. (2005). SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling. Journal of Clinical Investigation. 116(1). 90–100. 144 indexed citations
7.
Shen, Lei, et al.. (2004). Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity. Nature Biotechnology. 22(12). 1546–1553. 225 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nourredine Himoudi Breakdown of academic impact, for papers by Joanna Stanson Breakdown of academic impact, for papers by Lorenzo Uccellini Breakdown of academic impact, for papers by Bas Pilzecker Breakdown of academic impact, for papers by Susanne Oberle Breakdown of academic impact, for papers by R Brew Breakdown of academic impact, for papers by Irina Smirnow Breakdown of academic impact, for papers by Salim Dhanji Breakdown of academic impact, for papers by Shengwu Liu Breakdown of academic impact, for papers by Matthew F. Mackey
Rankless by CCL
2026